Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2021-04-30
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peribulbar Rocuronium in Adult Strabismus Surgery
NCT04821817
Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal
NCT03046719
Prevention of Complications of Eye Surgery
NCT00478907
Efficacy of Oxalidine and Sufentanil in Strabismus Correction
NCT07112157
Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid
NCT01350024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20 patients receive Subconjunctival bupivacaine of the end of the surgery
20 patients receive Subconjunctival bupivacaine in the end of operation and monitoring postoperative pain score
Iocal anaesthetic bupivacaine
Local anaesthetic Subconjunctival bupivacaine
20 patients receive Subconjunctival placebo in the end of operation
20 patients receive Subconjunctival placebo in the end of operation and monitoring postoperative pain score
Placebo
0.9 saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iocal anaesthetic bupivacaine
Local anaesthetic Subconjunctival bupivacaine
Placebo
0.9 saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Anaesthesiologist Association physical states I,II.
* singed informed consent to participate in the study and were scheduled for strabismus operations under general anaesthesia.
Exclusion Criteria
* ocular hypertension.
* inability to communicate.
* history of hematological disease.
* allergy to local anesthetic drugs.
14 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fayoum University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
abeer shaban
Lecture of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammad A Hamed, MD
Role: STUDY_DIRECTOR
Fayoum University Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Subconjunctival bupivacaine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.